337 related articles for article (PubMed ID: 29096156)
1. Recurrence dynamics of breast cancer according to baseline body mass index.
Biganzoli E; Desmedt C; Fornili M; de Azambuja E; Cornez N; Ries F; Closon-Dejardin MT; Kerger J; Focan C; Di Leo A; Nogaret JM; Sotiriou C; Piccart M; Demicheli R
Eur J Cancer; 2017 Dec; 87():10-20. PubMed ID: 29096156
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
[TBL] [Abstract][Full Text] [Related]
3. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
4. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
5. Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients.
Venturelli E; Orenti A; Fabricio ASC; Garrone G; Agresti R; Paolini B; Bonini C; Gion M; Berrino F; Desmedt C; Coradini D; Biganzoli E
BMC Cancer; 2018 Jun; 18(1):651. PubMed ID: 29895278
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction.
Kneubil MC; Brollo J; Botteri E; Curigliano G; Rotmensz N; Goldhirsch A; Lohsiriwat V; Manconi A; Martella S; Santillo B; Petit JY; Rietjens M
Eur J Surg Oncol; 2013 Mar; 39(3):260-5. PubMed ID: 23313014
[TBL] [Abstract][Full Text] [Related]
7. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
8. Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients.
Mazzarella L; Disalvatore D; Bagnardi V; Rotmensz N; Galbiati D; Caputo S; Curigliano G; Pelicci PG
Eur J Cancer; 2013 Nov; 49(17):3588-97. PubMed ID: 23953055
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
[TBL] [Abstract][Full Text] [Related]
10. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
11. Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast.
Demicheli R; Ardoino I; Boracchi P; Coradini D; Agresti R; Ferraris C; Gennaro M; Hrushesky WJ; Biganzoli E
BMC Cancer; 2010 Nov; 10():656. PubMed ID: 21118508
[TBL] [Abstract][Full Text] [Related]
12. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
13. Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer.
Warren LE; Ligibel JA; Chen YH; Truong L; Catalano PJ; Bellon JR
Ann Surg Oncol; 2016 Nov; 23(12):3870-3879. PubMed ID: 27448118
[TBL] [Abstract][Full Text] [Related]
14. Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).
Ligibel JA; Cirrincione CT; Liu M; Citron M; Ingle JN; Gradishar W; Martino S; Sikov W; Michaelson R; Mardis E; Perou CM; Ellis M; Winer E; Hudis CA; Berry D; Barry WT
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26113580
[TBL] [Abstract][Full Text] [Related]
15. Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
Demicheli R; Bonadonna G; Hrushesky WJ; Retsky MW; Valagussa P
Breast Cancer Res; 2004; 6(6):R689-96. PubMed ID: 15535851
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
Yamashita H; Ogiya A; Shien T; Horimoto Y; Masuda N; Inao T; Osako T; Takahashi M; Endo Y; Hosoda M; Ishida N; Horii R; Yamazaki K; Miyoshi Y; Yasojima H; Tomioka N;
Breast Cancer; 2016 Nov; 23(6):830-843. PubMed ID: 26467036
[TBL] [Abstract][Full Text] [Related]
17. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
[TBL] [Abstract][Full Text] [Related]
18. Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study.
Elwood JM; Tin Tin S; Kuper-Hommel M; Lawrenson R; Campbell I
BMC Cancer; 2018 Jan; 18(1):76. PubMed ID: 29334917
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer in postmenopausal patients: Impact of age.
Abu Rabi Z; Zoranovic T; Milovanovic J; Todorovic-Rakovic N; Nikolic-Vukosavljevic D
J BUON; 2015; 20(3):723-9. PubMed ID: 26214623
[TBL] [Abstract][Full Text] [Related]
20. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
